CTXR
Price
$0.86
Change
-$0.00 (-0.00%)
Updated
Jan 14 closing price
Capitalization
17.91M
Intraday BUY SELL Signals
VERA
Price
$48.41
Change
-$0.69 (-1.41%)
Updated
Jan 14 closing price
Capitalization
3.43B
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTXR vs VERA

Header iconCTXR vs VERA Comparison
Open Charts CTXR vs VERABanner chart's image
Citius Pharmaceuticals
Price$0.86
Change-$0.00 (-0.00%)
Volume$184.42K
Capitalization17.91M
Vera Therapeutics
Price$48.41
Change-$0.69 (-1.41%)
Volume$1.27M
Capitalization3.43B
CTXR vs VERA Comparison Chart in %
View a ticker or compare two or three
VS
CTXR vs. VERA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Hold and VERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CTXR: $0.86 vs. VERA: $48.41)
Brand notoriety: CTXR and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 19% vs. VERA: 79%
Market capitalization -- CTXR: $17.91M vs. VERA: $3.43B
CTXR [@Biotechnology] is valued at $17.91M. VERA’s [@Biotechnology] market capitalization is $3.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than CTXR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 6 TA indicator(s) are bullish while VERA’s TA Score has 3 bullish TA indicator(s).

  • CTXR’s TA Score: 6 bullish, 3 bearish.
  • VERA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CTXR is a better buy in the short-term than VERA.

Price Growth

CTXR (@Biotechnology) experienced а -6.70% price change this week, while VERA (@Biotechnology) price change was -0.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

VERA is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($3.43B) has a higher market cap than CTXR($17.9M). CTXR YTD gains are higher at: 11.042 vs. VERA (-4.404). CTXR has higher annual earnings (EBITDA): -43.9M vs. VERA (-244.06M). VERA has more cash in the bank: 497M vs. CTXR (6.09M). CTXR has less debt than VERA: CTXR (1.88M) vs VERA (77.2M). CTXR (0) and VERA (0) have equivalent revenues.
CTXRVERACTXR / VERA
Capitalization17.9M3.43B1%
EBITDA-43.9M-244.06M18%
Gain YTD11.042-4.404-251%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.09M497M1%
Total Debt1.88M77.2M2%
FUNDAMENTALS RATINGS
CTXR: Fundamental Ratings
CTXR
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTXRVERA
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 23 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CTXR
Daily Signal:
Gain/Loss:
VERA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TNXP16.901.27
+8.13%
Tonix Pharmaceuticals Holding Corp
EL116.911.54
+1.33%
Estee Lauder Companies (The)
CLBT17.55-0.45
-2.50%
Cellebrite DI Ltd
ZCMD0.55-0.02
-3.32%
Zhongchao
OMDA15.50-0.63
-3.91%
Omada Health Inc

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with KLTO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then KLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
+0.65%
KLTO - CTXR
42%
Loosely correlated
-6.04%
HYPD - CTXR
32%
Poorly correlated
+6.93%
ALEC - CTXR
31%
Poorly correlated
-3.65%
VERA - CTXR
28%
Poorly correlated
-1.41%
TAOX - CTXR
28%
Poorly correlated
+9.19%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-1.41%
KYMR - VERA
53%
Loosely correlated
+1.46%
LYRA - VERA
52%
Loosely correlated
-5.03%
VYGR - VERA
41%
Loosely correlated
+2.74%
BNTX - VERA
41%
Loosely correlated
+1.80%
CRNX - VERA
41%
Loosely correlated
+2.04%
More